- Argentina
- Australia
- Austria
- Bangladesh
- Belgium
- Botswana
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Colombia
- Cuba
- Czech Republic
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Germany
- Ghana
- Greece
- Hong Kong
- Hungary
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Latvia
- Lebanon
- Lithuania
- Malaysia
- Mexico
- Morocco
- Namibia
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Senegal
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Turkey
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- Venezuela
- Vietnam
- Zimbabwe
Taiwan Health News API
Get the live top health headlines from Taiwan with our JSON API.
Get API key for the Taiwan Health News APIAPI Demonstration
This example demonstrates the HTTP request to make and the JSON response you will receive when you use the news api to get the top headlines from Taiwan.
GET
https://gnews.io/api/v4/top-headlines?country=tw&category=health&apikey=API_KEY
{
"totalArticles": 1824,
"articles": [
{
"id": "53e293b1c65c6a9028bfbae461735dbb",
"title": "佩圖思跨足代謝肝病領域,創新免疫療法登 EASL 受關注",
"description": "佩圖思生醫股份有限公司(簡稱佩圖思)近日於 2026 年歐洲肝臟研究學會年會(EASL 2026)發表旗下候選藥物 PLT012 的最新臨床前研究成果,在多種疾病模型中,觀察到可降低脂肪堆積、減緩發炎與纖維化、改善肝損傷指標,並促使免疫細胞組成朝低發炎狀態轉變,展現其作為多適應症平臺之潛力。",
"content": "專注於開發新型代謝檢查點免疫療法以治療肝臟及腸胃道癌症的生物製藥新創,佩圖思生醫股份有限公司(簡稱佩圖思, Pilatus Biosciences Inc.)近日於 2026 年歐洲肝臟研究學會年會(European Association for the Study of the Liver Congress 2026, EASL 2026)發表旗下候選藥物 PLT012 的最新臨床前研究成果,在多種疾病模型中,觀察到可降低脂肪堆積、減緩發炎與纖維化、改善肝損傷指標,並促使免疫細胞組成朝低發炎... [3151 chars]",
"url": "https://geneonline.news/pilatus-easl-026newsjune-utm_sourcegoogleutm_mediumpost_0602utm_campaignpilatus/",
"image": "https://geneonline.news/wp-content/uploads/2026/06/EASL.png",
"publishedAt": "2026-06-02T03:36:50Z",
"lang": "zh",
"source": {
"id": "594fc058c841290e428c6bac3314195d",
"name": "GeneOnline News",
"url": "https://geneonline.news"
}
},
{
"id": "79ec865a13c7b53f5efd30a0986d322e",
"title": "「被遺忘的器官」竟能預測壽命?科學家揭密人體健康新指標",
"description": "數十年來,醫學院學生被教導胸腔內的胸腺只是個青春期過後就基本停止運作的小器官。但最新研究顯示,這個長",
"content": "數十年來,醫學院學生被教導胸腔內的胸腺只是個青春期過後就基本停止運作的小器官。但最新研究顯示,這個長期被忽視的器官可能是決定人們如何老化、以及能否抵抗致命疾病的主開關。\n來自波士頓Mass General Brigham的研究團隊利用人工智慧分析超過27,000份醫學掃描影像,發現擁有健康、活躍胸腺的成年人壽命更長,對抗癌症與心臟病的能力也顯著更強。這項發表於今年3月18日Nature期刊上的雙研究,可能改變醫師預測病患長期健康的方式。\n胸腺就像是T細胞的訓練營,而T細胞正是免疫系統中負責辨識並... [1006 chars]",
"url": "https://n.yam.com/Article/20260602540790",
"image": "https://ni.yam.com/20260602/stock_health_007-3d9caca147c8c561.webp",
"publishedAt": "2026-06-02T03:08:00Z",
"lang": "zh",
"source": {
"id": "34810a99b30e7ec9256aae29e7ae383a",
"name": "蕃新聞",
"url": "https://n.yam.com"
}
},
{
"id": "55a03a15e951508687c68913bbc3028d",
"title": "伊波拉和漢坦疫情為何令科學家困惑",
"description": "這兩次疫情中,伊波拉病毒和漢坦病毒的類型與此前的病毒種類大不相同,這引發了關於如何應對的新問題。科學家表示,這說明我們對病毒仍存在巨大的認知空白。",
"content": "本月,兩種病毒佔據了新聞頭條。先是一艘郵輪上暴發了漢坦病毒疫情,導致多達13人感染,其中三人死亡。緊接著,非洲爆發了伊波拉疫情,截至目前已導致900多人感染,220人死亡。\n在兩起事件中,相關新聞不僅令人驚恐,而且令人困惑,甚至對科學家來說也是如此。此次漢坦病毒的表現似乎不再像漢坦病毒,而伊波拉病毒的表現也不再像伊波拉病毒。\n漢坦病毒由嚙齒動物和其他動物攜帶,通常通過吸入動物的乾尿液和唾液感染人類。但在宏迪烏斯號郵輪上,漢坦病毒卻在人際傳播。\n至於非洲的疫情,科學家們近年來在對抗伊波拉方面已經取... [1740 chars]",
"url": "https://cn.nytimes.com/health/20260528/ebola-hantavirus-species-strains/zh-hant/",
"image": "https://static01.nyt.com/images/2026/05/22/multimedia/00SCI-VIRUSES-01-pmzl/00SCI-VIRUSES-01-pmzl-articleLarge.jpg",
"publishedAt": "2026-05-28T05:56:37Z",
"lang": "zh",
"source": {
"id": "9845ba8ad62e421b65009850185744e4",
"name": "纽约时报中文网",
"url": "https://cn.nytimes.com"
}
}
]
}